These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31051118)

  • 1. Comparing bleeding patterns for the levonorgestrel 52 mg, 19.5 mg, and 13.5 mg intrauterine systems.
    Goldthwaite LM; Creinin MD
    Contraception; 2019 Aug; 100(2):128-131. PubMed ID: 31051118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding pattern and user satisfaction in second consecutive levonorgestrel-releasing intrauterine system users: results of a prospective 5-year study.
    Heikinheimo O; Inki P; Schmelter T; Gemzell-Danielsson K
    Hum Reprod; 2014 Jun; 29(6):1182-8. PubMed ID: 24682613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding patterns for the Liletta
    Schreiber CA; Teal SB; Blumenthal PD; Keder LM; Olariu AI; Creinin MD
    Eur J Contracept Reprod Health Care; 2018 Apr; 23(2):116-120. PubMed ID: 29560743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amenorrhea rates and predictors during 1 year of levonorgestrel 52 mg intrauterine system use.
    Darney PD; Stuart GS; Thomas MA; Cwiak C; Olariu A; Creinin MD
    Contraception; 2018 Mar; 97(3):210-214. PubMed ID: 29038072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen for the prevention of unscheduled bleeding in new users of the levonorgestrel 52-mg intrauterine system: a randomized controlled trial.
    Cohen MA; Simmons KB; Edelman AB; Jensen JT
    Contraception; 2019 Nov; 100(5):391-396. PubMed ID: 31226322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of baseline bleeding pattern on amenorrhea with levonorgestrel intrauterine system use.
    Mejia M; McNicholas C; Madden T; Peipert JF
    Contraception; 2016 Nov; 94(5):556-560. PubMed ID: 27364099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mifepristone treatment prior to insertion of a levonorgestrel releasing intrauterine system for improved bleeding control - a randomized controlled trial.
    Papaikonomou K; Kopp Kallner H; Söderdahl F; Gemzell-Danielsson K
    Hum Reprod; 2018 Nov; 33(11):2002-2009. PubMed ID: 30295731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding and spotting with the levonorgestrel 13.5 mg intrauterine system: the impact of insertion timing.
    Shimoni N; Choudhury T; Goldman AR; Frondelli M; Chen PH
    Contraception; 2019 Jun; 99(6):340-344. PubMed ID: 30831104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding pattern difference between levonorgestrel intrauterine system and copper intrauterine devices inserted immediately post-abortion: a multicenter, prospective, observational cohort study in Chinese women.
    Chen X; Li Q; Wang X; Chen J; Lv W; Shi B; Wang H; Luo J; Li J
    Curr Med Res Opin; 2018 May; 34(5):873-880. PubMed ID: 29298525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pain and bleeding pattern related to levonorgestrel intrauterine system (LNG-IUS) insertion.
    Van Schoubroeck D; Van den Bosch T; Ameye L; Veldman J; Hindryckx A; Werbrouck E; Timmerman D
    Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):154-6. PubMed ID: 24029596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception.
    Bilgehan F; Dilbaz B; Karadag B; Deveci CD
    J Obstet Gynaecol Res; 2015 Sep; 41(9):1426-32. PubMed ID: 26180028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D; Schacht E
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby A; Hussain M; Rishworth JR; Rees MC
    Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby AE; Cooke I; Rees M
    Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levonorgestrel-releasing intrauterine system (LNG-IUS 12) for prevention of pregnancy for up to five years.
    Nelson AL
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):833-842. PubMed ID: 28617060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding.
    Chen BA; Eisenberg DL; Schreiber CA; Turok DK; Olariu AI; Creinin MD
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S888.e1-S888.e6. PubMed ID: 31866516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding patterns with the 19.5 mg LNG-IUS, with special focus on the first year of use: implications for counselling.
    Beckert V; Ahlers C; Frenz AK; Gerlinger C; Bannemerschult R; Lukkari-Lax E
    Eur J Contracept Reprod Health Care; 2019 Aug; 24(4):251-259. PubMed ID: 31223042
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of mifepristone in reducing intermenstrual vaginal bleeding in users of the levonorgestrel intrauterine system.
    Lal S; Kriplani A; Kulshrestha V; Sharma M; Agarwal N
    Int J Gynaecol Obstet; 2010 May; 109(2):128-30. PubMed ID: 20223454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of the levonorgestrel-releasing intrauterine system position on bleeding patterns in reproductive age women.
    Alves RDMS; Rabelo MM; Andrade VR; Cabral RCS; Merriman JW; Brito MB
    Int J Gynaecol Obstet; 2019 Dec; 147(3):326-331. PubMed ID: 31489621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.